Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Orchard Therapeutics Plc ADR (ORTX)

Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Orchard Therapeutics Plc ADR 245 HAMMERSMITH ROAD 3RD FLOOR LONDON X0 W6 8PW GBR

www.orchard-tx.com P: 203-384-6700

Description:

Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 380,109
Enterprise Value, $K 334,679
Shares Outstanding, K 22,761
Annual Sales, $ 22,660 K
Annual Net Income, $ -150,660 K
Last Quarter Sales, $ 6,300 K
Last Quarter Net Income, $ -35,320 K
EBIT, $ -102,020 K
EBITDA, $ -99,860 K
60-Month Beta 0.55
% of Insider Shareholders 2.91%
% of Institutional Shareholders 29.90%
Float, K 22,099
% Float 97.09%
Short Volume Ratio 0.14

Growth:

1-Year Return 165.50%
3-Year Return -70.96%
5-Year Return -87.01%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/13/23
Latest Earnings Date 03/04/24
Earnings Per Share ttm -0.94
EPS Growth vs. Prev Qtr -114.29%
EPS Growth vs. Prev Year 95.95%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 03/10/23

ORTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -74.94%
Return-on-Assets % -33.51%
Profit Margin % -664.87%
Debt/Equity 0.20
Price/Sales 13.17
Price/Cash Flow N/A
Price/Book 4.73
Book Value/Share 3.53
Interest Coverage -48.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar